Literature DB >> 18395359

Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus.

Anna Rabbani1, Robert J Amdur, Anthony A Mancuso, John W Werning, Jessica Kirwan, Christopher G Morris, William M Mendenhall.   

Abstract

PURPOSE: To report the long-term results after definitive radiotherapy (RT) for T1-T2 pyriform sinus squamous cell carcinoma. PATIENTS AND METHODS: The data from 123 patients with T1-T2 pyriform sinus squamous cell carcinoma treated with RT with or without neck dissection between November 1964 and June 2003 were analyzed. The median follow-up for all patients was 3.2 years, and the median follow-up for living patients was 10.7 years.
RESULTS: The 5-year local control, locoregional control, freedom from distant metastasis, cause-specific survival, and overall survival rate was 85%, 70%, 75%, 61%, and 35%, respectively. The ultimate local control rate, including successful salvage of RT failure, for T1 and T2 cancer patients was 96% and 94%, respectively. The overall local control rate with a functional larynx was 83%. Pretreatment computed tomography tumor volume data were available for 55 patients. The median computed tomography tumor volume was 4.2 cm(3) (range, 0-22.4). Local control was worse for patients with a tumor volume >6.5 cm(3) compared with those with a smaller tumor volume. Of the 123 patients, 16% developed moderate to severe acute (2%), late (9%), or postoperative (5%) complications.
CONCLUSIONS: Local control with larynx preservation after definitive RT for T1-T2 pyriform sinus squamous cell carcinoma likely results in local control and survival similar to that after total laryngectomy or larynx-conserving surgery. Two-thirds of our living patients retained a functional larynx.

Entities:  

Mesh:

Year:  2008        PMID: 18395359     DOI: 10.1016/j.ijrobp.2008.01.003

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma?

Authors:  William M Mendenhall; Primož Strojan; Avraham Eisbruch; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

2.  Primary radiotherapy for squamous cell carcinoma of the pyriform sinus.

Authors:  William M Mendenhall; Robert J Amdur; Christopher G Morris; Jessica Kirwan; Peter T Dziegielewski; John W Werning
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-14       Impact factor: 2.503

3.  Definitive radiotherapy for early-stage hypopharyngeal squamous cell carcinoma.

Authors:  Kaname Sato; Akira Kubota; Madoka Furukawa; Yousuke Kitani; Yuko Nakayama; Tetsuo Nonaka; Nobutaka Mizoguchi; Miho Shiomi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-18       Impact factor: 2.503

4.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

5.  Early hypopharyngeal cancer treated with different therapeutic approaches: a single-institution cohort analysis.

Authors:  Nalee Kim; Jeongshim Lee; Kyung Hwan Kim; Jong Won Park; Chang Geol Lee; Ki Chang Keum
Journal:  Radiat Oncol J       Date:  2016-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.